Cambridge Investment Research Advisors’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
7,334
-402
-5% -$68.5K ﹤0.01% 1998
2026
Q1
$1.39M Sell
7,736
-967
-11% -$192K ﹤0.01% 1892
2025
Q4
$1.89M Sell
8,703
-1,295
-13% -$284K 0.01% 1574
2025
Q3
$2.56M Sell
9,998
-1,604
-14% -$403K 0.01% 1319
2025
Q2
$3.01M Buy
11,602
+1,415
+14% +$360K 0.01% 1146
2025
Q1
$2.48M Buy
10,187
+4,204
+70% +$1.06M 0.01% 1211
2024
Q4
$1.52M Sell
5,983
-4,542
-43% -$1.22M 0.01% 1555
2024
Q3
$3.09M Sell
10,525
-116
-1% -$32.7K 0.01% 1065
2024
Q2
$2.58M Buy
10,641
+70
+0.7% +$16.7K 0.01% 1121
2024
Q1
$2.83M Buy
10,571
+681
+7% +$173K 0.01% 1059
2023
Q4
$2.45M Buy
9,890
+4,233
+75% +$859K 0.01% 1077
2023
Q3
$1.04M Buy
5,657
+937
+20% +$191K ﹤0.01% 1552
2023
Q2
$1.11M Sell
4,720
-31
-0.7% -$6.53K 0.01% 1537
2023
Q1
$964K Sell
4,751
-993
-17% -$207K ﹤0.01% 1600
2022
Q4
$1.12M Sell
5,744
-33
-0.6% -$6.03K 0.01% 1450
2022
Q3
$990K Sell
5,777
-127
-2% -$24.9K 0.01% 1489
2022
Q2
$1.08M Sell
5,904
-104
-2% -$20.8K 0.01% 1425
2022
Q1
$1.43M Sell
6,008
-30
-0.5% -$7.07K 0.01% 1346
2021
Q4
$1.77M Sell
6,038
-5,266
-47% -$1.47M 0.01% 1217
2021
Q3
$2.87M Sell
11,304
-68
-0.6% -$17.7K 0.01% 894
2021
Q2
$2.72M Hold
11,372
0.01% 948
2021
Q1
$2.06M Buy
11,372
+90
+0.8% +$15.9K 0.01% 994
2020
Q4
$2.18M Sell
11,282
-871
-7% -$146K 0.01% 881
2020
Q3
$1.91M Sell
12,153
-67
-0.5% -$11K 0.01% 829
2020
Q2
$2.1M Buy
12,220
+4
+0% +$593 0.02% 751
2020
Q1
$1.46M Buy
12,216
+120
+1% +$17.5K 0.01% 791
2019
Q4
$1.7M Buy
12,096
+102
+0.9% +$14.1K 0.01% 861
2019
Q3
$1.69M Sell
11,994
-781
-6% -$110K 0.01% 823
2019
Q2
$1.73M Sell
12,775
-471
-4% -$59.1K 0.02% 776
2019
Q1
$1.57M Buy
13,246
+6,548
+98% +$699K 0.02% 816
2018
Q4
$624K Buy
6,698
+4,894
+271% +$521K 0.01% 1206
2018
Q3
$236K Buy
+1,804
New +$235K ﹤0.01% 1950
2017
Q3
Sell
-5,573
Closed -$766K 2017
2017
Q2
$766K Sell
5,573
-1,102
-17% -$151K 0.01% 947
2017
Q1
$913K Buy
6,675
+1,727
+35% +$220K 0.02% 766
2016
Q4
$585K Buy
4,948
+1,922
+64% +$235K 0.01% 941
2016
Q3
$407K Buy
3,026
+1,087
+56% +$144K 0.01% 1144
2016
Q2
$249K Buy
+1,939
New +$235K 0.01% 1270
2016
Q1
Sell
-1,836
Closed -$204K 1612
2015
Q4
$204K Sell
1,836
-709
-28% -$76.6K ﹤0.01% 1361
2015
Q3
$247K Sell
2,545
-128
-5% -$12.7K 0.01% 1126
2015
Q2
$260K Buy
2,673
+299
+13% +$29.2K 0.01% 1131
2015
Q1
$221K Buy
+2,374
New +$211K 0.01% 1190

Other funds holding EFX

Cambridge Investment Research Advisors's EFX Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Equifax (EFX) stake by 5.2% in Q2 2026, selling an estimated $68.5K and leaving 7,334 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1998.

Cambridge Investment Research Advisors first reported a position in EFX in Q1 2015 and has held it in 41 quarters since. The position peaked at $3.09M in Q3 2024. 192 funds tracked by Wall St. Rank hold EFX as of Q2 2026.

  • Cambridge Investment Research Advisors held 7,334 shares of Equifax worth $1.16M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 402 Equifax shares in Q2 2026, an estimated $68.5K.
  • Equifax made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1998 holding.
  • Cambridge Investment Research Advisors first reported a position in Equifax in Q1 2015 and has held it in 41 quarters since.
  • Cambridge Investment Research Advisors's Equifax position peaked at $3.09M in Q3 2024.
  • 192 funds tracked by Wall St. Rank held Equifax as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.